Zobrazeno 1 - 10
of 105
pro vyhledávání: '"aggressive natural killer-cell leukemia"'
Autor:
Caroline Spaner, Jessica Durkee-Shock, Andrew Weng, Ryan Stubbins, Alina S. Gerrie, Stefania Pittaluga, Jeffrey I. Cohen, Luke Y. C. Chen
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
Aggressive natural killer cell leukemia (ANKL) is a rare, aggressive hematologic malignancy which often presents as fulminant Epstein-Barr virus (EBV)- driven hemophagocytic lymphohistiocytosis (HLH). ANKL lacks a distinct immunologic and morphologic
Externí odkaz:
https://doaj.org/article/1f102fdc58414ddf8bb572486cac9b94
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 3, Pp 225-226 (2023)
Externí odkaz:
https://doaj.org/article/ede2255150114a099b298e91d51ee2c6
Autor:
Yi Miao, Jing Zhang, Qingqing Chen, Lingxiao Xing, Tonglu Qiu, Huayuan Zhu, Li Wang, Lei Fan, Wei Xu, Jianyong Li
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Limited data are available about the underlying causes of hemophagocytic lymphohistiocytosis (HLH) in adults. We collected and analyzed the data of 555 cases of adult HLH. HLH in 242 patients were malignancies-related and lymphoid malignancies (42.0%
Externí odkaz:
https://doaj.org/article/dc403eccf83048478a30f54c0c7f8a75
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
Aggressive natural killer cell leukemia (ANKL) is a rare malignant tumor, especially uncommon in children. ANKL has very aggressive clinical course and bad prognosis and is usually caused by Epstein-Barr virus infection. ANKL often has clinical manif
Externí odkaz:
https://doaj.org/article/1f76fd90fe974c59a3a3a8282b96ae3f
Autor:
Austin B. Henslee, Timothy A. Steele
Publikováno v:
Biomarker Research, Vol 6, Iss 1, Pp 1-11 (2018)
Abstract Background Aggressive natural killer cell leukemia is a devastating disease, with an average patient survival time of less than 2 months following diagnosis. Due to P-glycoprotein-mediated resistance of the tumor cells most forms of chemothe
Externí odkaz:
https://doaj.org/article/1b508ad402ed43dd9c911313cc59b1a2
Publikováno v:
Diagnostic Pathology, Vol 12, Iss 1, Pp 1-5 (2017)
Abstract Background Aggressive natural killer cell leukemia/lymphoma (ANKL) is a rare and highly aggressive NK cell neoplasm with a short clinical course and poor prognosis and is often misdiagnosed and confused with NK/T cell lymphoma (NKTL), which
Externí odkaz:
https://doaj.org/article/226c414a2e0c4bc8956a56161c7a7643
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Aggressive natural killer cell leukemia (ANKL) is a rare natural killer cell neoplasm characterized by systemic infiltration of Epstein–Barr virus and rapidly progressive clinical course. ANKL can be accompanied with hemophagocytic lymph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ca7ede5e3e2c8dc09bde184622d2d3e
https://doi.org/10.12998/wjcc.v9.i34.10708
https://doi.org/10.12998/wjcc.v9.i34.10708
Publikováno v:
International Medical Case Reports Journal, Vol Volume 10, Pp 389-391 (2017)
Ying Hu, Jingbo Wang Department of Hematology, Aerospace Center Hospital, Beijing, People’s Republic of China Abstract: Aggressive natural killer (NK) cell leukemia is a rare hematological malignancy. It often presents with a rapidly declining clin
Externí odkaz:
https://doaj.org/article/42d2652d0f644a85958a4f6024dc0dbe
Publikováno v:
Expert Review of Hematology. 14:731-740
Introduction Aggressive natural killer cell leukemia (ANKL) is a rare hematologic malignancy characterized by the EBV-driven proliferation of mature natural killer cells. It mostly frequently affects younger adults and has a fulminant course with a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e6482568281983210ec50f920f5e26f
https://doi.org/10.1080/17474086.2021.1955345
https://doi.org/10.1080/17474086.2021.1955345